JP2014505733A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014505733A5 JP2014505733A5 JP2013554551A JP2013554551A JP2014505733A5 JP 2014505733 A5 JP2014505733 A5 JP 2014505733A5 JP 2013554551 A JP2013554551 A JP 2013554551A JP 2013554551 A JP2013554551 A JP 2013554551A JP 2014505733 A5 JP2014505733 A5 JP 2014505733A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- oxymetazoline
- composition according
- amount
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161443210P | 2011-02-15 | 2011-02-15 | |
| US61/443,210 | 2011-02-15 | ||
| PCT/US2012/025068 WO2012112566A1 (en) | 2011-02-15 | 2012-02-14 | Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017002106A Division JP6389534B2 (ja) | 2011-02-15 | 2017-01-10 | 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014505733A JP2014505733A (ja) | 2014-03-06 |
| JP2014505733A5 true JP2014505733A5 (enExample) | 2015-04-09 |
| JP6225030B2 JP6225030B2 (ja) | 2017-11-01 |
Family
ID=45757218
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013554551A Active JP6225030B2 (ja) | 2011-02-15 | 2012-02-14 | 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物 |
| JP2017002106A Active JP6389534B2 (ja) | 2011-02-15 | 2017-01-10 | 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物 |
| JP2018153450A Abandoned JP2018193399A (ja) | 2011-02-15 | 2018-08-17 | 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017002106A Active JP6389534B2 (ja) | 2011-02-15 | 2017-01-10 | 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物 |
| JP2018153450A Abandoned JP2018193399A (ja) | 2011-02-15 | 2018-08-17 | 酒さの症状を治療するためのオキシメタゾリンの薬学的クリーム組成物 |
Country Status (11)
| Country | Link |
|---|---|
| US (4) | US20120208858A1 (enExample) |
| EP (2) | EP2675449B1 (enExample) |
| JP (3) | JP6225030B2 (enExample) |
| KR (2) | KR20190114010A (enExample) |
| CN (2) | CN107007546A (enExample) |
| AU (3) | AU2012217858A1 (enExample) |
| BR (1) | BR112013020770A2 (enExample) |
| CA (1) | CA2827373C (enExample) |
| ES (2) | ES2742273T3 (enExample) |
| RU (1) | RU2648439C2 (enExample) |
| WO (1) | WO2012112566A1 (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9486408B2 (en) | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
| MX2007009796A (es) | 2007-08-14 | 2009-02-25 | Cell Therapy And Technology S | Gel conteniendo pirfenidona. |
| CA2827373C (en) | 2011-02-15 | 2019-05-14 | Epi Health, Llc | Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea |
| US20120225918A1 (en) * | 2011-03-03 | 2012-09-06 | Voom, Llc | Compositions and Methods for Non-Surgical Treatment of Ptosis |
| MX2011007675A (es) | 2011-07-19 | 2012-07-11 | Cell Therapy And Technology S A De C V | Procedimiento para la fabricacion de una composicion farmaceutica en forma de tabletas de liberacion prolongada conteniendo pirfenidona y su aplicacion en la regresion de la insuficiencia renal cronica, contractura capsular mamaria y fibrosis hepatica humanas. |
| AU2012289968B2 (en) * | 2011-08-04 | 2014-01-16 | Omeros Corporation | Stable anti-inflammatory solutions for injection |
| IN2014CN02961A (enExample) | 2011-09-20 | 2015-07-03 | Altavista Inst De Invest Medica S A S | |
| MX346763B (es) | 2012-03-28 | 2017-03-31 | Cell Therapy And Tech S A De C V | Composición tópica semisólida conteniendo pirfenidona y dialil óxido de disulfuro modificado (odd-m) para eliminar o prevenir el acné. |
| MX356551B (es) | 2012-08-23 | 2018-06-04 | Grupo Medifarma S A De C V Star | Composición antiséptica, antiseborreica y exfoliante para eliminar o prevenir el acné. |
| FR3000395A1 (fr) * | 2012-12-31 | 2014-07-04 | Galderma Res & Dev | Combinaison de laropiprant et d'oxymetazoline pour le traitement de la rosacee |
| CA2899342C (en) | 2013-02-01 | 2021-09-21 | Ocularis Pharma, Llc | Methods and compositions for daily ophthalmic administration of phentolamine to improve visual performance |
| DK2950648T3 (da) | 2013-02-01 | 2019-12-02 | Ocuphire Pharma Inc | Vandige oftalmiske opløsninger af phentolamin og medicinske anvendelser deraf |
| CA2928962A1 (en) * | 2013-10-28 | 2015-05-07 | Astion Pharma A/S | Dermatological compositions |
| AU2015252947B2 (en) * | 2014-05-01 | 2020-07-09 | Anterios, Inc. | Demonstrable efficacy across or within patient populations |
| CA2951725C (en) * | 2014-06-11 | 2022-06-07 | Allergan, Inc. | Stabilized oxymetazoline formulations and their uses |
| WO2017049148A1 (en) * | 2015-09-17 | 2017-03-23 | June Jacobs Laboratiories, Llc | Compositions and methods for the treatment and prevention of radiation dermatitis |
| US10744135B2 (en) * | 2016-06-28 | 2020-08-18 | Doris Maria HEXSEL | Use of an active substance in the treatment of melasma |
| EP3541358A1 (en) | 2016-11-21 | 2019-09-25 | Eirion Therapeutics, Inc. | Transdermal delivery of large agents |
| EA202090763A1 (ru) * | 2017-11-15 | 2020-08-03 | Борис Славинович ФАРБЕР | Фармацевтическая композиция для стимуляции деления стволовых клеток и подавления вирулентности бактерий |
| MX368750B (es) | 2018-08-31 | 2019-10-15 | Cell Therapy And Tech S A De C V | Composiciones farmaceuticas semisolidas de base oleosa conteniendo pirfenidona para su aplicacion en la reparacion tisular. |
| WO2020056191A1 (en) | 2018-09-13 | 2020-03-19 | Eirion Therapeutics, Inc. | Uses of plasminogen activator inhibitor 1 (pai-1) inhibitors |
| JP2022508715A (ja) | 2018-10-15 | 2022-01-19 | オキュフィア・ファーマ・インコーポレイテッド | 緑内障および関連状態の処置のための方法および組成物 |
| DK3870170T3 (da) | 2018-10-26 | 2026-05-26 | Opus Genetics Inc | Behandling af presbyopi og mydriasis med fentolamin |
| EP3860592A4 (en) * | 2018-11-26 | 2023-04-19 | Cellix Bio Private Limited | OPHTHALMIC COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN AND EYE DISEASES |
| US20220204456A1 (en) * | 2019-04-30 | 2022-06-30 | Generos Biopharma Ltd. | Compound for treating autoimmune skin diseases caused by inflammation, and use thereof |
| CN115368310B (zh) | 2021-05-18 | 2025-06-27 | 奥库菲尔医药公司 | 合成甲磺酸酚妥拉明的方法 |
| KR102633256B1 (ko) * | 2021-10-08 | 2024-02-05 | (주)우리스마트바이오 | 참당귀 추출물을 이용한 피부개선용 화장품 조성물, 이를 포함한 피부개선용 화장품 및 피부개선용 화장품 제조방법 |
| US20250114362A1 (en) * | 2022-01-05 | 2025-04-10 | Asymmetric Therapeutics, Llc | Methods and compositions for treatment of cutaneous proliferative disorders and other skin conditions |
| US20240423959A1 (en) * | 2022-06-21 | 2024-12-26 | Jjr&D, Llc | Topical benzimidazole formulations and methods for use in treating inflammatory dermatoses |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3147275A (en) | 1964-09-01 | Nh-cha | ||
| US8093293B2 (en) * | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
| US6433024B1 (en) | 2000-05-08 | 2002-08-13 | Karl F. Popp | Topical anti-acne composition |
| KR100898879B1 (ko) | 2000-08-16 | 2009-05-25 | 돌비 레버러토리즈 라이쎈싱 코오포레이션 | 부수 정보에 응답하여 하나 또는 그 이상의 파라메터를변조하는 오디오 또는 비디오 지각 코딩 시스템 |
| US6479060B1 (en) * | 2001-09-04 | 2002-11-12 | Healthpoint, Ltd. | Elegant hydrogenated castor oil ointments |
| US6824786B2 (en) | 2001-11-27 | 2004-11-30 | Ruey J. Yu | Compositions comprising phenyl-glycine derivatives |
| US6573301B1 (en) | 2002-04-23 | 2003-06-03 | Bradley Pharmaceuticals, Inc. | Carbamide peroxide compositions for the treatment of dermatological disorders and methods for their use |
| US7439241B2 (en) | 2003-05-27 | 2008-10-21 | Galderma Laboratories, Inc. | Compounds, formulations, and methods for treating or preventing rosacea |
| US7812049B2 (en) | 2004-01-22 | 2010-10-12 | Vicept Therapeutics, Inc. | Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α1-adrenoceptor agonists |
| ES2424644T3 (es) * | 2004-05-25 | 2013-10-07 | Galderma Pharma S.A. | Compuestos, formulaciones y métodos para tratar o prevenir los trastornos inflamatorios de la piel |
| DK1833495T3 (da) | 2005-03-15 | 2008-06-02 | Campina Nederland Holding Bv | Dermatologisk anvendelse af mælkeproteiner |
| WO2006105450A2 (en) * | 2005-03-30 | 2006-10-05 | Revance Therapeutics, Inc. | Compositions and methods for treating acne |
| WO2007000192A1 (en) | 2005-06-29 | 2007-01-04 | Dsm Ip Assets B.V. | Topical compositions comprising nanoparticles of an isoflavone |
| EP1998788A4 (en) * | 2006-03-01 | 2011-08-03 | Ruey J Yu | COMPOSITIONS AND METHODS FOR THE TOPIC TREATMENT OF DERMATOLOGICAL DISORDERS RESPONSIBLE FOR TAR |
| US20080031979A1 (en) * | 2006-08-04 | 2008-02-07 | Claude Saliou | Use of extracts for the treatment of viral disorders |
| RU2310439C1 (ru) * | 2006-10-05 | 2007-11-20 | Закрытое акционерное общество Фармацевтическое научно-производственное предприятие "Ретиноиды" (ЗАО "Ретиноиды") | Мазевая акарицидная композиция и способ лечения демодекоза и сопутствующих ему заболеваний |
| US9511016B2 (en) * | 2007-06-12 | 2016-12-06 | Epicentrx, Inc. | Topical composition for treating pain |
| US20090061020A1 (en) | 2007-08-31 | 2009-03-05 | Theobald Klaus P | Brimonidine Compositions for Treating Erythema |
| PT2818184T (pt) | 2007-11-16 | 2019-01-28 | Aclaris Therapeutics Inc | Composições e métodos para o tratamento de púrpura |
| US20090130029A1 (en) * | 2007-11-21 | 2009-05-21 | Foamix Ltd. | Glycerol ethers vehicle and pharmaceutical compositions thereof |
| MX2012004890A (es) | 2009-10-26 | 2012-09-28 | Galderma Pharma Sa | Metodos para tratar o prevenir eritema agudo. |
| US20120082625A1 (en) | 2010-09-28 | 2012-04-05 | Michael Graeber | Combination treatment for rosacea |
| DK2645993T3 (en) | 2010-12-03 | 2017-02-13 | Allergan Inc | Pharmaceutical cream compositions comprising oxymetazoline |
| CA2827373C (en) | 2011-02-15 | 2019-05-14 | Epi Health, Llc | Pharmaceutical cream compositions of oxymetazoline for treating symptoms of rosacea |
| CA2841632A1 (en) | 2011-07-14 | 2013-01-17 | Allergan, Inc. | Gel compositions of oxymetazoline and methods of use |
-
2012
- 2012-02-14 CA CA2827373A patent/CA2827373C/en active Active
- 2012-02-14 BR BR112013020770-1A patent/BR112013020770A2/pt not_active Application Discontinuation
- 2012-02-14 CN CN201710280045.2A patent/CN107007546A/zh active Pending
- 2012-02-14 CN CN2012800179627A patent/CN103458897A/zh active Pending
- 2012-02-14 ES ES12705755T patent/ES2742273T3/es active Active
- 2012-02-14 EP EP12705755.2A patent/EP2675449B1/en active Active
- 2012-02-14 EP EP19170085.5A patent/EP3578178B1/en active Active
- 2012-02-14 WO PCT/US2012/025068 patent/WO2012112566A1/en not_active Ceased
- 2012-02-14 KR KR1020197028285A patent/KR20190114010A/ko not_active Withdrawn
- 2012-02-14 AU AU2012217858A patent/AU2012217858A1/en not_active Abandoned
- 2012-02-14 RU RU2013141845A patent/RU2648439C2/ru active
- 2012-02-14 JP JP2013554551A patent/JP6225030B2/ja active Active
- 2012-02-14 US US13/396,165 patent/US20120208858A1/en not_active Abandoned
- 2012-02-14 ES ES19170085T patent/ES3068788T3/es active Active
- 2012-02-14 KR KR1020137024232A patent/KR102058756B1/ko active Active
-
2013
- 2013-12-30 US US14/144,106 patent/US20140113947A1/en not_active Abandoned
-
2017
- 2017-01-10 JP JP2017002106A patent/JP6389534B2/ja active Active
- 2017-04-26 AU AU2017202726A patent/AU2017202726B2/en active Active
-
2018
- 2018-08-17 JP JP2018153450A patent/JP2018193399A/ja not_active Abandoned
-
2019
- 2019-02-05 US US16/267,590 patent/US20190167566A1/en not_active Abandoned
- 2019-06-07 AU AU2019203993A patent/AU2019203993B2/en active Active
- 2019-11-04 US US16/673,549 patent/US11541000B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010222367A5 (enExample) | ||
| RU2013141845A (ru) | Фармацевтическая композиция в виде крема, содержащая оксиметазолин, для лечения симптомов розацеа | |
| MX2016009666A (es) | Suministro topico de composiciones para la piel que tienen ph bajo. | |
| PH12017502092A1 (en) | Topical pharmaceutical compositions | |
| SA518391624B1 (ar) | Ror- منظمات جاما | |
| MX362485B (es) | Nuevos inhibidores de rock. | |
| BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
| BR112015029512A2 (pt) | derivados de pirazolopirrolidina e seu uso no tratamento de doenças | |
| HRP20191919T1 (hr) | Donori nitroksila sa poboljšanim terapijskim indeksom | |
| CO2019008053A2 (es) | Agente terapéutico para enfermedades del hígado | |
| WO2015085143A3 (en) | Therapeutic agents for skin diseases and conditions | |
| UA109991C2 (xx) | Карбаматні сполуки, їх отримання і застосування | |
| PH12013500215B1 (en) | Corticosteroids for the treatment of joint pain | |
| AR093247A1 (es) | Agente profilactico y/o terapeutico para sintomas conductuales y psicologicos asociados con la enfermedad neurodegenerativa o sintomas impulsivos asociados con enfermedad mental que contiene brexpiprazol o sales del mismo | |
| ME02841B (me) | Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze | |
| MX2013003635A (es) | Compuestos de n-heteroarilo. | |
| JP2017537936A5 (enExample) | ||
| WO2017022962A8 (ko) | Ripk 억제제를 유효성분으로 포함하는 면역질환의 예방 또는 치료용 조성물 | |
| NZ720328A (en) | Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease | |
| MX2024000828A (es) | Formulaciones de parasiticida de isoxazolina y metodos para el tratamiento de la blefaritis. | |
| WO2017182873A3 (en) | Peptide-oligourea foldamer compounds and methods of their use | |
| WO2019004788A3 (ko) | 브라우쏘칼콘 a를 유효성분으로 포함하는 염증성 장질환 예방 또는 치료용 약학 조성물 | |
| JP2016538288A5 (enExample) | ||
| BR112015028581A2 (pt) | composição farmacêutica de dosagem baixa, utilização do ácido, método para o tratamento da doença inflamatória e composição farmacêutica | |
| BR112016029761A8 (pt) | composições compreendendo um derivado de ácido quinolona carboxílico e agentes efervescentes, uso das mesmas e forma cristalina do referido derivado |